Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates

American Journal of Dermatopathology

Volumn 30, Issue 5, 2008, Pages 425-430

  Morales, Anjali V ^a   Arber, Daniel A ^b   Seo, Katie ^b   Kohler, Sabine ^a,b   Kim, Youn H ^a   Sundram, Uma N ^a,b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BIOMED 2; Clonality; Cutaneous B cell lymphoma; PCR

Indexed keywords

IMMUNOGLOBULIN; RITUXIMAB; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CLONAL VARIATION; CONTROLLED STUDY; CUTANEOUS B CELL LYMPHOMA; FEMALE; HUMAN; LYMPHOCYTIC INFILTRATION; MALE; MULTIMODALITY CANCER THERAPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SKIN LYMPHOMA; ADOLESCENT; BIOPSY; CASE CONTROL STUDY; CELL PROLIFERATION; DIFFERENTIAL DIAGNOSIS; GENE TRANSLOCATION; GENETICS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SKIN DISEASE; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; BIOPSY; CASE-CONTROL STUDIES; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN KAPPA-CHAINS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SKIN DISEASES; SKIN NEOPLASMS; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 58149277234     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31818118f7     Document Type: Article

References (45)

1. Willemze R. Primary cutaneous B-cell lymphoma: classification and treatment. Curr Opin Oncol. 2006;16:425-431.
2. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
3. Langerak AW, Van Krieken JH, Wolvers-Tettero IL, et al. The role of molecular analysis of immunoglobulin and T cell receptor gene rearrangements in the diagnosis of lymphoproliferative disorders. J Clin Pathol. 2001;5:565-567.
4. Wan JH, Trainor KJ, Brisco MJ, et al. Monoclonality in B cell lymphoma detection in the paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol. 1990;43:888-890.
5. Gonzalez M, Gonzalez D, Lopez-Perez R, et al. Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies. Haematologica. 1999;84:779-784.
6. Derksen PW, Langerak AW, Kerkhof E, et al. Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B-cell neoplasia. Mod Pathol. 1999;12:794-805.
7. Sandberg Y, Heule F, Lam K, et al. Molecular immunoglobulin/T-cell receptor clonality analysis in cutaneous lymphoproliferations. Experience with the Biomed-2 standardized polymerase chain reaction protocol. Haematologica. 2003;88:659-670.
8. Signoretti S, Murphy M, Puddu P, et al. Clonality of cutaneous B-cell infiltrates determined by microdissection and immunoglobulin gene rearrangement. Diagn Mol Pathol. 1999;8:176-182.
9. Hughes J, Weston S, Bennetts B, et al. The application of a PCR technique for the detection of immunoglobulin heavy chain gene rearrangements in fresh or paraffin-embedded skin tissue. Pathology. 2001;33:222-225.
10. Lukowsky A, Marchwat M, Sterry W, et al. Evaluation of B-cell clonality in archival skin biopsy samples of cutaneous B-cell lymphoma by immunoglobulin heavy chain gene polymerase chain reaction. Leuk Lymphoma. 2006;47:487-493.
11. Alaibac M, Belloni-Fortina A, Mori M, et al. Immunoglobulin heavy chain variable region family expression in primary cutaneous follicle center cell lymphomas. Br J Dermatol. 2001;144:862-865.
12. Buoloc A, Delfau-Larue MH, Lenormand B, et al. Polymerase chain reaction analysis of immunoglobulin gene rearrangement in cutaneous lymphoid hyperplasias. French Study Group for Cutaneous Lymphomas. Arch Dermatol. 1999;135:168-172.
13. Cerroni L, Signoretti S, Hoffler G, et al. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol. 1997;21:1307-1315.
14. Child FJ, Woolford AJ, Calonje E, et al. Molecular analysis of the immunoglobulin heavy chain gene in the diagnosis of primary cutaneous B-cell lymphoma. J Invest Dermatol. 2001;117:984-989.
15. Ritter JH, Wick MR, Adesokan PM, et al. Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement. Am J Clin Pathol. 1997;108:60-68.
16. Cerroni L, Arzberger E, Putz B, et al. Primary cutaneous follicle center cell lymphoma with follicular growth pattern. Blood. 2000;95:3922-3928.
17. van Dongen JJM, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BHMH4-CT98-3936. Leukemia. 2003;17:2257-2317.
18. van Krieken JH, Langerak AW, Macintyre EA, et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007;21: 201-206.
19. van der Velden VH, de Bie M, van Wering ER, et al. Immunoglobulin light chain gene rearrangements in precursor-B-acute lymphoblastic leukemia: characteristics and applicability for the detection of minimal residual disease. Haematologica. 2006;91:679-682.
20. Matthews C, Catherwood MA, Morris TCM, et al. Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols. Leuk Lymphoma. 2004;45:1899-1904.
21. Matthews C, Catherwood MA, Morris TCM, et al. Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression. Eur J Haematol. 2006;77:309-317.
22. Langerak AW, Molina TJ, Lavender FL, et al. Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoprolifera-tions: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007;21:222-229.
23. Evans PA, Pott CH, Groenen PJ, et al. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007;21:207-214.
24. McClure RF, Kaur P, Pagel E, et al. Validation of immunoglobulin gene rearrangement detection by PCR using commercially available BIOMED-2 primers. Leukemia. 2006;20:176-179.
25. Liu H, Bench AJ, Bacon CM, et al. A practical strategy for the routine use of BIOMED-2 PCR assays for detection of B-and T-cell clonality in diagnostic haematopathology. Brit J Hematol. 2007;138:31-43.
26. Wood GS, Ngan BY, Tung R, et al. Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia. Am J Pathol. 1989;135:13.
27. Hammer E, Sangueza O, Suwanjindar P, et al. Immunophenotypic and genotypic analysis in cutaneous lymphoid hyperplasias. J Am Acad Dermatol. 1993;28:426.
28. Rijlaarsdam U, Bakel V, van Oostveen JW, et al. Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: differential diagnostic and pathogenetic aspects. J Invest Dermatol. 1992;99:749.
29. Bagg A, Braziel RM, Arber DA, et al. Immunoglobulin heavy chain gene analysis in lymphomas. J Mol Diagn. 2002;4:81-89.
30. Arber DA. Molecular diagnostic approach to non-Hodgkin's lymphoma. J Mol Diagn. 2000;4:178-190.
31. Segal GH, Jorgensen T, Scott M, et al. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: I. Low grade B-cell lympho-proliferative disorders of non-follicular center cell type. Hum Pathol. 1994;25:1269-1275.
32. Cerroni L, Volkenandt M, Rieger E, et al. Bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas. J Invest Dermatol. 1994;102: 231-235.
33. Weiss LM, Warnke RA, Sklar J, et al. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med. 1987;317:1185-1189.
34. Limpens J, de Jong D, van Krieken JH, et al. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene. 1999;6: 2271-2276.
35. Volkenandt M, Cerroni L, Rieger E, et al. Analysis of the 14;18 translocation in cutaneous lymphomas using the polymerase chain reaction. J Cutan Pathol. 1992;19:353-356.
36. Neri A, Fracchiolla NS, Roscetti E, et al. Molecular analysis of cutaneous B-and T-cell lymphomas. Blood. 1995;86:3160-3172.
37. Bergman R, Kurtin PJ, Gibson LE, et al. Clinicopathologic, immunophenotypic, and molecular characterization of primary cutaneous follicular B-cell lymphoma. Arch Dermatol. 2001;137:432-439.
38. Palmedo G, Hantschke M, Rutten A, et al. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma? Am J Dermatopathol. 2007;29:231-236.
39. Gronbaek K, Moller PH, Nedergaard T, et al. Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic, and genotypic study of 21 cases. Br J Dermatol. 2000;142:913-923.
40. Delia D, Borrello MG, Beri E, et al. Clonal immunoglobulin rearrangements and normal T-cell receptor, bcl-2, and c-myc genes in primary cutaneous B cell lymphomas. Cancer Res. 1989;49:4901-4905.
41. Kneba M, Eick S, Herbst H, et al. Frequency and structure of t(14;18) major breakpoint regions in non-Hodgkin's lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing. Cancer Res. 1991;51:3243-3250.
42. Child FJ, Russell-Jones R, Woolford AJ, et al. Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma. Br J Dermatol. 2001;144:735-744.
43. Catherwood MA, Alexander HD, McManus DT, et al. Immunoglobulin gene rearrangement investigations in the diagnosis of lymphoid malignancies from formaldehyde-fixed biopsies. Leuk Lymphoma. 2003;44:645-648.
44. Amara K, Trimeche M, Ziadi S, et al. PCR-based analysis of B-cell lymphomas in paraffin-embedded tissues: diagnostic value of immunoglobulin k and l light chain gene rearrangement investigation. Pathol Res Pract. 2006;202:425-431.
45. Halldorsdottir AM, Zehnbauer BA, Burack WR. Application of BIOMED-2 clonality assays to formalin-fixed paraffin embedded follicular lymphoma specimens: superior performance of the IGK assays compared to IGH for suboptimal specimens. Leuk Lymphoma. 2007;48: 1338-1343.